Naveen Pemmaraju/mdanderson.org
Dec 25, 2024, 18:19
IACH’s latest post: ASH24 Webinar with Naveen Pemmaraju
IACH shared on X:
“Don’t miss our latest post- ASH24 webinar:
The Most Important MPN Studies
Featuring Prof. Naveen Pemmaraju
Now available on demand at IACH.
Watch the full library for FREE.”
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.
His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 25, 2024, 18:19
Dec 25, 2024, 18:00
Dec 25, 2024, 17:57
Dec 25, 2024, 17:52
Dec 25, 2024, 17:27
Dec 25, 2024, 17:26
Dec 25, 2024, 17:09